Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry (Q39537501)

12 September 2017

title

Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry (English)

1 reference

12 September 2017

1 reference

Ulas Darda Bayraktar

1

1 reference

12 September 2017

Tae Kon Kim

2

1 reference

12 September 2017

Katherine Drews-Elger

3

1 reference

12 September 2017

Cara Benjamin

4

1 reference

12 September 2017

Dorraya El-Ashry

5

1 reference

12 September 2017

Eric Wieder

6

1 reference

12 September 2017

Krishna V Komanduri

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

24 May 2011

1 reference

Breast Cancer Research and Treatment

12 September 2017

published in

1 reference

12 September 2017

volume

129

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

623-628

1 reference

describes a project that uses

12 September 2017

1 reference

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Endocrine-responsive breast cancer and strategies for combating resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Flow cytometry: a new approach for the molecular profiling of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1586-Z

10.1007/S10549-011-1586-Z

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference